Company Filing History:
Years Active: 2003
Title: The Innovative Contributions of Sheila J. Miknyoczki
Introduction:
Sheila J. Miknyoczki, an inventive mind located in Easton, PA, has made significant strides in the field of cancer treatment. With one patent to her name, she showcases a remarkable ability to blend scientific research with practical applications that have the potential to save lives.
Latest Patents:
Miknyoczki's groundbreaking patent, titled "Method of treating cancer with anti-neurotrophin agents," presents a novel approach to combating cancer. This method details a framework for treating or preventing cancer by administering a therapeutically effective amount of at least one anti-neurotrophin agent to mammals. Notably, the anti-neurotrophin agents described include antibodies, antisense molecules, small organic molecules, or dominant-negative mutations of trk receptors, all aimed at neutralizing neurotrophins such as NGF, BDNF, NT-3, NT-4/5, NT-6, or NT-7. This innovative treatment is particularly advantageous for individuals suffering from prostate or pancreatic cancer.
Career Highlights:
Sheila J. Miknyoczki has primarily contributed her expertise while working at Cephalon, Inc., where she has engaged in pioneering research aimed at improving patient outcomes in oncology. Her work reflects a commitment to advancing medical science to address critical health challenges.
Collaborations:
Throughout her career, Miknyoczki has collaborated with esteemed colleagues, including Karen J. Buchkovich and Craig A. Dionne. These partnerships demonstrate her ability to work effectively within teams, creating a collaborative environment that fosters innovation and propels research forward.
Conclusion:
Sheila J. Miknyoczki stands out as an important figure in the realm of cancer research and treatment. Her patent for a method of treating cancer with anti-neurotrophin agents exemplifies her innovative thinking and dedication to finding effective solutions for complex health issues. As researchers continue to build on her foundational work, the potential benefits for patients battling cancer are immense.